ZURICH (dpa-AFX Broker) - The major Swiss bank UBS has given Merck KGaA a "Buy" rating with a target price of 186 euros after the quarterly figures. The pharmaceutical and specialty chemicals company clearly exceeded expectations, analyst Matthew Weston praised in an initial reaction on Wednesday. His and the consensus estimates were within the outlook quantified for the first time./gl/zb

Publication of the original study: 15.05.2024 / 05:31 / GMT First dissemination of the original study: 15.05.2024 / 05:31 / GMT

-----------------------

dpa-AFX Broker - the Trader News from dpa-AFX

-----------------------